H. Nascimento

Cardiac rehabilitation in older patients: Indication or limitation?

A. Rocha, M. J. Maciel, R. Pinto, 2021, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

J. Seeley, C. Giaquinto, O. Kobusingye, 2021, BMC Infectious Diseases.

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Ana C. Matos, C. Königs, C. Giaquinto, 2022, The lancet. HIV.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Ana C. Matos, C. Königs, J. Seeley, 2022, The lancet. HIV.

Role of Left Ventricle Function in Cardiac Rehabilitation Outcomes in Stage B Heart Failure Patients

A. Rocha, M. J. Maciel, R. Pinto, 2019, Journal of cardiopulmonary rehabilitation and prevention.

Benefits of Cardiac Rehabilitation in Coronary Artery Disease

A. Rocha, M. J. Maciel, R. Pinto, 2019, Journal of cardiopulmonary rehabilitation and prevention.

TAVI in TAVI: new paradigm

C. Sousa, F. Macedo, M. J. Maciel, 2020, Acta cardiologica.